goBalto is an online service that enables users to identify, evaluate and manage CROs and CMOs from all over the world that meet their specific requirements (www.goBalto.com).  Through our exclusive relationship with goBalto, ChinaBio has provided goBalto with our database of over 260 China-based CROs and CMOs developed by our in-house research team.  ChinaBio goes further by providng CRO/CMO selection and management services to help our clients partner with China-baed CROs/CMOs that meet their specific requirements and that are know to provide high quality services and products based on our in-depth analysis (see www.ChinaBioLLC.com/crocmoservices).

"Sourced by ChinaBio®"

China-based CROs and CMOs provided to goBalto by ChinaBio are identified as "Sourced by ChinaBio" on goBalto's website.  This means that ChinaBio has identified these organizations as active CROs/CMOs in China, and that we maintain information relating to their capabilities in our proprietary database.  Additional information on these organizations is available to our clients on a project basis.

"Reviewed by ChinaBio®"

ChinaBio has reviewed over 40 CROs/CMOs throughout greater China, including meet with senior management, visiting their operations in China and reviewing their specific capabilities.  These organizations receive the "Reviewed by ChinaBio" stamp on goBalto's site.  While every client project is different and requires specific analysis to select the right partner, our insights into the capabilities and quality of these organizations can save our clients signicant time and reduce the risk in selecting a critical partner for their drug development program.

ChinaBio® CRO/CMO Services

Seleting and managing a CRO/CMO partner is always a daunting task even in the US - in China, it can be even more challenging.  While the benefits of cost and speed are significant, the distance, the language barrier and cultural differences all add up to an increased need for on-the-ground assistance in China. 

If you need in-depth analysis of your potential partners' capabilities, assistance selecting the right partner for your project, management oversight of projects based in China, or review of your China development strategy, ChinaBio can help.  Our team of experts based in Shanghai and the U.S. have significant expertise in leading CMC, pre-clinical and clinical studies, and have taken drugs from discovery to FDA approval for major pharmas using both in-house and outsourced project teams. 

This combination of FDA experience with our deep knowledge of China make ChinaBio the right partner to help ensure the success of your China-based proejcts.

See www.ChinaBioLLC.com/crocmoservices or contact us to learn more.